Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 15/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.47 |
| ▸ | AR | P10275 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19748474 | 1.00 | PARP1 (0.64) | PARP1LMNAENPP1ARCYP3A4 | |
| SCHEMBL14234308 | 0.96 | PARP1 (0.63) | PARP1LMNAENPP1ARCYP3A4 | |
| SCHEMBL29655251 | 0.96 | PARP1 (0.63) | PARP1LMNAENPP1ARCYP3A4 | |
| SCHEMBL29655088 | 0.89 | PARP1 (0.63) | PARP1LMNAENPP1ARCYP3A4 | |
| SCHEMBL19747669 | 0.89 | PARP1 (0.63) | PARP1LMNAENPP1ARCYP3A4 | |
| SCHEMBL29483966 | 0.88 | PARP1 (0.72) | PARP1LMNAENPP1ARCYP3A4 | |
| SCHEMBL4572876 | 0.88 | PARP1 (0.72) | PARP1LMNAENPP1ARCYP3A4 | |
| SCHEMBL29655224 | 0.88 | PARP1 (0.68) | PARP1LMNAENPP1ARCYP3A4 | |
| SCHEMBL19748607 | 0.88 | PARP1 (0.68) | PARP1LMNAENPP1ARCYP3A4 | |
| SCHEMBL29654940 | 0.88 | PARP1 (0.61) | PARP1LMNAENPP1CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109843874-B | Phthalazine derivatives useful as inhibitors of PARP1, PARP2 and/or tubulin for the treatment of cancer | 加利福尼亚大学董事会 | 2022-05-27 | — | — | CN | disclosed |